The ASX is holding steady near record highs on Friday, as earnings season drive sharp moves across the board.
Uranium stocks in the ASX could see big boosts to their valuations if Shaw and Partners' bold US$200/lb price forecast comes true.
American Uranium has confirmed uranium mineralisation along trend north of Mine Unit 2 at its Lo Herma project in Wyoming.
Neurizon Therapeutics doses the first participant in Regimen I of the HEALEY ALS platform trial.
HyTerra is entering a Collaboration Agreement with Prometheus Hydrogen to demonstrate a geologic hydrogen value chain in the US.
